Kiniksa Pharmaceuticals International, plc (KNSA) Operating cash flow 2017–2025
Kiniksa Pharmaceuticals International, plc (KNSA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$138.0MFY2025 · since FY2017: -$50.2M → $138.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $138.0M | +437.1% |
| FY2024 | $25.7M | +93.1% |
| FY2023 | $13.3M | +129.1% |
| FY2022 | $5.8M | +104.6% |
| FY2021 | -$126.3M | +7.5% |
| FY2020 | -$136.5M | +13.8% |
| FY2019 | -$158.4M | -95.5% |
| FY2018 | -$81.0M | -61.3% |
| FY2017 | -$50.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KNSA financial trends
KNSA RevenueKNSA Net incomeKNSA Net marginKNSA Gross profitKNSA Gross marginKNSA Operating incomeKNSA Operating marginKNSA Free cash flowKNSA Capital expendituresKNSA Return on equityKNSA Stock buybacksKNSA Dividends paidKNSA Total assetsKNSA Total liabilitiesKNSA Shareholders’ equityKNSA overview →